Tapentadol immediate release: a new treatment option for acute pain management

Tapentadol immediate release: a new treatment option for acute pain management

Marc Afilalo1, Jens-Ulrich Stegmann2, David Upmalis31Sir Mortimer B. Davis Jewish General Hospital, Montr&eacute;al, Canada; 2Global Drug Safety, Gr&uuml;nenthal GmbH, Aachen, Germany; 3Johnson &amp; Johnson Pharmaceutical Research and Development, L.L.C., Raritan, New Jersey...

Full description

Bibliographic Details
Main Authors:	Marc Afilalo, Jens-Ulrich Stegmann, David Upmalis
Format:	Article
Language:	English
Published:	Dove Medical Press 2010-02-01
Series:	Journal of Pain Research
Online Access:	http://www.dovepress.com/tapentadol-immediate-release-a-new-treatment-option-for-acute-pain-man-a3951

Similar Items

Post Hoc Analyses of Data from a 90-Day Clinical Trial Evaluating the Tolerability and Efficacy of Tapentadol Immediate Release and Oxycodone Immediate Release for the Relief of Moderate to Severe Pain in Elderly and Nonelderly Patients
by: Gary Vorsanger, et al.
Published: (2011-01-01)

Efficiency and safety of Tapentadol with immediate release for postoperative analgesia in cardiac surgery patients
by: L. S. Sorokina, et al.
Published: (2023-06-01)

Analgesic Efficacy and Safety of Tapentadol Immediate Release in Bunionectomy: A Meta-Analysis
by: Lorenzo Franco-de la Torre, et al.
Published: (2023-09-01)

New opioid analgesic tapentadol in the treatment of neuropathic pain in oncology
by: R. R. Sarmanaeva, et al.
Published: (2019-06-01)

Tapentadol in acute pain: a review of the results of international studies
by: V. V. Nikoda
Published: (2021-08-01)

Trends in dispensing and utilisation of sustained-release tapentadol in Australia.
by: Ximena Camacho, et al.
Published: (2022-08-01)

Tapentadol Immediate Release (IR) versus Morphine Hydrochloride for Postoperative Analgesia of Patients Undergoing Total Abdominal Hysterectomy—A Prospective Cohort Study
by: Sanja Starčević, et al.
Published: (2023-10-01)

Rhabdomyolysis associated with tapentadol abuse
by: Raghav Kannappan, et al.
Published: (2024-08-01)

Tapentadol Prolonged Release for Severe Chronic Osteoarthritis Pain in the Elderly—A Subgroup Analysis of Routine Clinical Practice Data
by: Andreas Schwittay, et al.
Published: (2020-01-01)

Tapentadol Prolonged Release Reduces the Severe Chronic Ischaemic Pain and Improves the Quality of Life in Patients with Type 2 Diabetes
by: Anna Tedeschi, et al.
Published: (2018-01-01)

Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease
by: Coluzzi F, et al.
Published: (2015-05-01)

Multiple Dose Pharmacokinetics of Tapentadol Oral Solution for the Treatment of Moderate to Severe Acute Pain in Children Aged 2 to <7 Years
by: Jończyk R, et al.
Published: (2022-09-01)

Tapentadol in the management of chronic low back pain: a novel approach to a complex condition?
by: Pergolizzi J, et al.
Published: (2011-07-01)

Pharmacodynamic characteristics and influencing factors of tapentadol for chronic pain relief under dose titration
by: Liang Xin, et al.
Published: (2025-01-01)

Comparison of preemptive analgesic efficacy of tapentadol and tramadol on postoperative pain in patients of lumbar laminectomy
by: Manojkumar N Gajbhare, et al.
Published: (2023-01-01)

Tapentadol as a drug of abuse – A preliminary report
by: Prakrithi Shivaprakash, et al.
Published: (2025-02-01)

Tapentadol vs oxycodone/naloxone in the management of pain after total hip arthroplasty in the fast track setting: an observational study
by: Tiziana D’Amato, et al.
Published: (2019-07-01)

Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study
by: Suzanne K Vosburg, et al.
Published: (2022-06-01)

Repurposed oral tapentadol as an intravenous drug of abuse in opioid dependence
by: Arshiya Fathima, et al.
Published: (2022-01-01)

Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study
by: Jordi Barrachina, et al.
Published: (2022-10-01)

Efetividade do tapentadol na dor oncológica - uma revisão sistemática
by: Ana Rita Aguadeiro Santos Baptista
Published: (2019-06-01)

Tapentadol nasal spray dependence: A reticent subtype of opioid dependence?
by: Navneet Venugopal, et al.
Published: (2024-11-01)

Adverse effects from counterfeit and mislabeled medicine containing tapentadol and carisoprodol
by: Gitte Plæhn, et al.
Published: (2024-08-01)

Effects of CYP2C19 variants on the metabolism of tapentadol in vitro
by: Ren-ai Xu, et al.
Published: (2022-05-01)

Analgesic efficacy of tapentadol in chronic joint disorders in horses: plasma serotonin concentration and adrenocortical response as biomarkers of pain-induced stress
by: Giovanna Lucrezia Costa, et al.
Published: (2024-12-01)

Novel Tapentadol Screen-Printed Carbon Sensor Integrated Copper Oxide Nanostructure
by: Razan M. Snari, et al.
Published: (2025-01-01)

Unraveling the Hippocampal Molecular and Cellular Alterations behind Tramadol and Tapentadol Neurobehavioral Toxicity
by: Cristiana Soares-Cardoso, et al.
Published: (2024-06-01)

Tapentadol: A Review of Experimental Pharmacology Studies, Clinical Trials, and Recent Findings
by: Alshehri FS
Published: (2023-03-01)

Effectiveness and tolerability of tapentadol in very elderly patients with assessment of cognitive-behavioral aspects
by: Eleonora Nunziata, et al.
Published: (2017-07-01)

Treatment-Continuity of ADHD Compared Using Immediate-Release and Extended-Release MPH
by: J Gordon Millichap
Published: (2005-07-01)

Efficacy and safety of multiple doses of tapentadol oral solution in the treatment of moderate to severe acute pain in children aged 2 to <18 years – a randomized, double-blind, placebo-controlled trial
by: Beuter C, et al.
Published: (2019-11-01)

Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR
by: Mike Durkin, et al.
Published: (2015-07-01)

Immediate Effects of Myofascial Release on the Thoracolumbar Fascia and Osteopathic Treatment for Acute Low Back Pain on Spine Shape Parameters: A Randomized, Placebo-Controlled Trial
by: Andreas Brandl, et al.
Published: (2021-08-01)

Prevalence and Profile of Tapentadol Use in Patients Visiting a Drug De-addiction Center in Kashmir
by: Syed Mehvish, et al.
Published: (2024-11-01)

Repeated Administration of Clinical Doses of Tramadol and Tapentadol Causes Hepato- and Nephrotoxic Effects in Wistar Rats
by: Joana Barbosa, et al.
Published: (2020-07-01)

Web-Based Discussion and Illicit Street Sales of Tapentadol and Oxycodone in Australia: Epidemiological Surveillance Study
by: Joshua Black, et al.
Published: (2021-12-01)

Estudo de biomarcadores de toxicidade decorrente da exposição de opioides: o tapentadol
by: Margarida Ferrão, et al.
Published: (2022-04-01)

New therapeutic options for musculoskeletal pain
by: A. В. Danilov, et al.
Published: (2019-04-01)

Tramadol and Tapentadol Induce Conditioned Place Preference with a Differential Impact on Rewarding Memory and Incubation of Craving
by: Joana Barbosa, et al.
Published: (2023-01-01)

Dispensación de fentanilo y tapentadol en farmacia comunitaria: adherencia farmacoterapéutica en dolor no oncológico
by: Daniel Reyes Estévez, et al.
Published: (2021-01-01)